Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.63 USD | -2.23% | -4.01% | -35.70% |
May. 13 | Morgan Stanley Lowers Price Target on Organogenesis Holdings to $3 From $3.50, Keeps Equalweight Rating | MT |
May. 10 | Health Care Edges Higher Amid Rotation to Utilities - Health Care Roundup | DJ |
Financials (USD)
Sales 2024 * | 456M | Sales 2025 * | 477M | Capitalization | 349M |
---|---|---|---|---|---|
Net income 2024 * | -1M | Net income 2025 * | 7M | EV / Sales 2024 * | 0.74 x |
Net cash position 2024 * | 9.83M | Net cash position 2025 * | 24.56M | EV / Sales 2025 * | 0.68 x |
P/E ratio 2024 * |
-263
x | P/E ratio 2025 * |
49.3
x | Employees | 862 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 66.51% |
Latest transcript on Organogenesis Holdings Inc.
1 day | -2.23% | ||
1 week | -4.01% | ||
Current month | +11.91% | ||
1 month | +15.10% | ||
3 months | -23.99% | ||
6 months | -0.75% | ||
Current year | -35.70% |
Managers | Title | Age | Since |
---|---|---|---|
Gary Gillheeney
CEO | Chief Executive Officer | 69 | 13-12-31 |
David Francisco
DFI | Director of Finance/CFO | 59 | 21-02-15 |
Patrick Bilbo
COO | Chief Operating Officer | 63 | 98-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Glenn Nussdorf
BRD | Director/Board Member | 70 | 02-12-31 |
Alan Ades
BRD | Director/Board Member | 86 | 02-12-31 |
Michael Driscoll
BRD | Director/Board Member | 63 | 22-02-14 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.20% | 25 M€ | -2.72% | - | |
0.09% | 28 M€ | -1.64% | ||
0.03% | 2 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-24 | 2.63 | -2.23% | 371,773 |
24-05-23 | 2.69 | -4.61% | 315,224 |
24-05-22 | 2.82 | +1.81% | 415,063 |
24-05-21 | 2.77 | 0.00% | 402,966 |
24-05-20 | 2.77 | +1.09% | 385,433 |
Delayed Quote Nasdaq, May 24, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-35.70% | 349M | |
+67.53% | 63.85B | |
-0.77% | 41.83B | |
+45.66% | 40.65B | |
-10.72% | 27.12B | |
+13.30% | 26.52B | |
-22.79% | 18.69B | |
+4.70% | 12.73B | |
+24.10% | 12.11B | |
+27.41% | 12.07B |
- Stock Market
- Equities
- ORGO Stock